Gaziano, T. A., Fonarow, G. C., Claggett, B., Chan, W. W., Deschaseaux-Voinet, C., Turner, S. J., … Solomon, S. D. (2016). Cost-effectiveness Analysis of Sacubitril/Valsartan vs Enalapril in Patients With Heart Failure and Reduced Ejection Fraction. JAMA Cardiology, 1(6), 666–666. https://doi.org/10.1001/jamacardio.2016.1747

Gaziano, Thomas A., Gregg C. Fonarow, Brian Claggett, Wing W. Chan, Celine Deschaseaux-Voinet, Stuart J. Turner, Jean L. Rouleau, Michael R. Zile, John J. V. McMurray, and Scott D. Solomon. “Cost-effectiveness Analysis of Sacubitril/Valsartan vs Enalapril in Patients With Heart Failure and Reduced Ejection Fraction.” JAMA Cardiology 1, no. 6 (September 1, 2016): 666–666. https://doi.org/10.1001/jamacardio.2016.1747.

Gaziano TA, Fonarow GC, Claggett B, Chan WW, Deschaseaux-Voinet C, Turner SJ, et al. Cost-effectiveness Analysis of Sacubitril/Valsartan vs Enalapril in Patients With Heart Failure and Reduced Ejection Fraction. JAMA Cardiology. 2016 Sep 1;1(6):666–666.

Gaziano, Thomas A., et al. “Cost-effectiveness Analysis of Sacubitril/Valsartan vs Enalapril in Patients With Heart Failure and Reduced Ejection Fraction.” JAMA Cardiology, vol. 1, no. 6, American Medical Association (AMA), Sept. 2016, pp. 666–666. Crossref, doi:10.1001/jamacardio.2016.1747.

Gaziano TA, Fonarow GC, Claggett B, Chan WW, Deschaseaux-Voinet C, Turner SJ, Rouleau JL, Zile MR, McMurray JJV, Solomon SD. Cost-effectiveness Analysis of Sacubitril/Valsartan vs Enalapril in Patients With Heart Failure and Reduced Ejection Fraction. JAMA Cardiology. American Medical Association (AMA); 2016 Sep 1;1(6):666–666.